Correlation between renal membrane binding and nephrotoxicity of aminoglycosides
- PMID: 3606061
- PMCID: PMC174778
- DOI: 10.1128/AAC.31.4.570
Correlation between renal membrane binding and nephrotoxicity of aminoglycosides
Abstract
The kinetics of aminoglycoside binding to renal brush border and basolateral membrane vesicles from rat renal cortex were studied by using [3H]amikacin. [3H]amikacin binding to renal membranes was found to be a rapid, saturable process with a fourfold greater affinity for basolateral membranes than for brush border membranes (Kd basolateral = 607 microM; Kd brush border = 2,535 microM). Renal membranes prepared from immature rats (2 to 3 weeks old) exhibited a significantly lower affinity compared with membranes from adults (Kd basolateral = 2,262 microM; Kd brush border = 6,216 microM). Additionally, the inhibitory behavior of several aminoglycosides versus [3H]amikacin binding to brush border membranes revealed the following rank order of potency: neomycin greater than tobramycin approximately gentamicin approximately netilmicin greater than amikacin approximately neamine greater than streptomycin. The relative insensitivity of immature rats to aminoglycoside-induced nephrotoxicity in vivo and the comparative nephrotoxicity of the various aminoglycosides suggest that renal membrane-binding affinity is closely correlated to the nephrotoxic potential of these antibiotics.
Similar articles
-
Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.J Pharmacol Exp Ther. 1986 Jun;237(3):919-25. J Pharmacol Exp Ther. 1986. PMID: 3754895
-
Uptake of aminoglycoside antibiotics into brush-border membrane vesicles and inhibition of (Na+ + K+)-ATPase activity of basolateral membrane.Biochim Biophys Acta. 1986 Nov 6;862(1):111-8. doi: 10.1016/0005-2736(86)90474-8. Biochim Biophys Acta. 1986. PMID: 3021218
-
Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity.J Pharmacol Exp Ther. 1995 Jul;274(1):258-63. J Pharmacol Exp Ther. 1995. PMID: 7616406
-
Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.Drug Metab Pharmacokinet. 2004 Jun;19(3):159-70. doi: 10.2133/dmpk.19.159. Drug Metab Pharmacokinet. 2004. PMID: 15499183 Review.
-
Renal ultrastructural and biochemical injuries induced by aminoglycosides.Environ Health Perspect. 1984 Aug;57:293-9. doi: 10.1289/ehp.8457293. Environ Health Perspect. 1984. PMID: 6389114 Free PMC article. Review.
Cited by
-
Aminoglycosides--50 years on.Br J Clin Pharmacol. 1995 Jun;39(6):597-603. Br J Clin Pharmacol. 1995. PMID: 7654476 Free PMC article. Review.
-
Angiogenin as a molecular target for the treatment of prostate cancer.Curr Cancer Ther Rev. 2011 May;7(2):83-90. doi: 10.2174/1573394711107020083. Curr Cancer Ther Rev. 2011. PMID: 21743803 Free PMC article.
-
Neamine is preferential as an anti-prostate cancer reagent by inhibiting cell proliferation and angiogenesis, with lower toxicity than cis-platinum.Oncol Lett. 2015 Jul;10(1):137-142. doi: 10.3892/ol.2015.3227. Epub 2015 May 19. Oncol Lett. 2015. PMID: 26170989 Free PMC article.
-
Neamine inhibits growth of pancreatic cancer cells in vitro and in vivo.J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):82-87. doi: 10.1007/s11596-016-1546-2. Epub 2016 Feb 3. J Huazhong Univ Sci Technolog Med Sci. 2016. PMID: 26838745
-
Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription.Clin Cancer Res. 2009 Mar 15;15(6):1981-8. doi: 10.1158/1078-0432.CCR-08-2593. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276260 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical